Rule detail : 183686

JPN FSA OTC Derivatives Trades

Updated on: Nov 23, 2023

Nov. 2023 Response to Comment
On Nov. 21, 2023, JPN FSA issued consultation feedback after receiving 7 comments.
Clarified scope and the need to be accurate to the minute in relation to the Fixing date.
FSA finalized the guides; reporting on delta and UPI will be required from Apr. 7, 2025.

JPN FSA proposed to require reporting mainly on unique product identifier (UPI), delta.
Aim to introduce new reporting requirements based on global trends and other factors.
Follows JPN FSA Dec. 2022 final guides on OTC derivatives trade data, see #136673.
Consultation Period
Comments by Oct. 2, 2023, with required reporting planned from Apr. 7, 2025.
Nov. 2023 Response to Comment
On Nov. 21, 2023, JPN FSA issued consultation feedback after receiving 7 comments.
Clarified scope and the need to be accurate to the minute in relation to the Fixing date.
FSA finalized the guides; reporting on delta and UPI will be required from Apr. 7, 2025.

Regulators

JPN FSA

Entity Types

B/D; Exch; FCM; OTC

Reference

Gd, FS, Trsl, PR, 11/21/2023; CP, Trsl, PR, 9/1/2023

Functions

Compliance; Operations; Record Retention; Reporting; Risk; Trade Reporting

Countries

Japan